These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23472209)

  • 1. Transscleral sustained vasohibin-1 delivery by a novel device suppressed experimentally-induced choroidal neovascularization.
    Onami H; Nagai N; Kaji H; Nishizawa M; Sato Y; Osumi N; Nakazawa T; Abe T
    PLoS One; 2013; 8(3):e58580. PubMed ID: 23472209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
    Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.
    Nagai N; Nezhad ZK; Daigaku R; Saijo S; Song Y; Terata K; Hoshi A; Nishizawa M; Nakazawa T; Kaji H; Abe T
    Int J Pharm; 2019 Aug; 567():118458. PubMed ID: 31247277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
    Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of laser-induced choroidal neovascularization by intravitreal vasohibin-1 in monkey eyes.
    Onami H; Nagai N; Machida S; Kumasaka N; Wakusawa R; Ishikawa Y; Sonoda H; Sato Y; Abe T
    Retina; 2012 Jun; 32(6):1204-13. PubMed ID: 22366904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transscleral Controlled Delivery of Geranylgeranylaceton Using a Polymeric Device Protects Rat Retina Against Light Injury.
    Nagai N; Kaji H; Nishizawa M; Nakazawa T; Abe T
    Adv Exp Med Biol; 2016; 854():471-7. PubMed ID: 26427448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the Small GTPase Rap1 Inhibits Choroidal Neovascularization by Regulating Cell Junctions and ROS Generation in Rats.
    Li J; Zhang R; Wang C; Wang X; Xu M; Ma J; Shang Q
    Curr Eye Res; 2018 Jul; 43(7):934-940. PubMed ID: 29601231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization.
    Zhao M; Xie W; Tsai SH; Hein TW; Rocke BA; Kuo L; Rosa RH
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1125-1133. PubMed ID: 29490350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A drug refillable device for transscleral sustained drug delivery to the retina.
    Nagai N; Saijo S; Song Y; Kaji H; Abe T
    Eur J Pharm Biopharm; 2019 Mar; 136():184-191. PubMed ID: 30690065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of ranibizumab using a porous poly(dimethylsiloxane) capsule suppressed laser-induced choroidal neovascularization via the transscleral route.
    Nagai N; Daigaku R; Motoyama R; Kaji H; Abe T
    J Mater Sci Mater Med; 2022 Dec; 34(1):5. PubMed ID: 36586040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules.
    Molokhia S; Papangkorn K; Butler C; Higuchi JW; Brar B; Ambati B; Li SK; Higuchi WI
    J Ocul Pharmacol Ther; 2020 May; 36(4):247-256. PubMed ID: 32155098
    [No Abstract]   [Full Text] [Related]  

  • 12. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT
    Mol Vis; 2013; 19():54-61. PubMed ID: 23335851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularization.
    Meyer JH; Larsen PP; Strack C; Harmening WM; Krohne TU; Holz FG; Schmitz-Valckenberg S
    Exp Eye Res; 2019 Jul; 184():162-171. PubMed ID: 31002822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-VEGFR2 Antibody-modified Micelle for Triggered Drug Delivery and Effective Therapy of Choroidal Neovascularization.
    Takahashi K; Masuda T; Harada M; Inoue T; Nakamura S; Naito K; Hara H; Shimazawa M
    Curr Neurovasc Res; 2019; 16(3):258-265. PubMed ID: 31258081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of experimental choroidal neovascularization by curcumin in mice.
    Xie P; Zhang W; Yuan S; Chen Z; Yang Q; Yuan D; Wang F; Liu Q
    PLoS One; 2012; 7(12):e53329. PubMed ID: 23285282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.
    Bae JH; Hwang AR; Kim CY; Yu HG; Koh HJ; Yang WI; Chang HR; Lee SC
    PLoS One; 2017; 12(6):e0180482. PubMed ID: 28666022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C induces suppression and regression of choroidal neovascularization- A murine model.
    Livnat T; Weinberger Y; Budnik I; Deitch I; Dahbash M; Sella R; Dardik R; Kenet G; Nisgav Y; Weinberger D
    Exp Eye Res; 2019 Sep; 186():107695. PubMed ID: 31201804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of choroidal neovascularization by intravitreal ketorolac.
    Kim SJ; Toma HS
    Arch Ophthalmol; 2010 May; 128(5):596-600. PubMed ID: 20457981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aspirin on models of retinal pigment epithelium pathology.
    Goyal S; Lyzogubov VV; Ali O; Bora PS; Bora NS; Uwaydat SH
    Clin Exp Ophthalmol; 2016 Sep; 44(7):610-617. PubMed ID: 26861462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
    Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
    Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.